1
Roland Cherif Cheikh: Sustained release of peptides from pharmaceutical compositions. Delab, Fish & Richardson P C, January 21, 1997: US05595760 (62 worldwide citation)

The invention features a method of administering a peptide to a patient and delivering the peptide continuously over an extended period of time of at least three days by obtaining a solid pharmaceutical composition including a soluble, gelable salt of the peptide and up to 30 percent, by weight, of ...


2
Cherif Cheikh Roland: Sustained release of peptides from pharmaceutical compositions. Sod Conseils Rech Applic, November 16, 2005: EP1595532-A2 (2 worldwide citation)

The invention features a solid, non-particulate, sustained-release pharmaceutical composition for parenteral administration to a patient. The composition consists essentially of (1) a soluble, gelable peptide salt, and (2) up to 30 percent, by weight, of a pharmaceutically acceptable, monomeric, sol ...


3
Cherif Cheikh Roland: Sustained release of peptides from pharmaceutical compositions. Delab, November 28, 2001: EP1157703-A2

The invention features a solid, non-particulate, sustained-release pharmaceutical composition for parenteral administration to a patient. The composition consists essentially of (1) a soluble, gelable peptide salt, and (2) up to 30 percent, by weight, of a pharmaceutically acceptable, monomeric, sol ...


4
Cherif Cheikh Roland: Liberation prolongee de peptides depuis des compositions pharmaceutiques, Sustained release of peptides from pharmaceutical compositions. Societe de Conseils de Recherches Et D Applications Scientifiques Sas, Ipsen Pharma Sas, SMART & BIGGAR, June 30, 2009: CA2198917

The invention features a solid, non-particulate, sustained-release pharmaceutical composition for parenteral administration to a patient. The composition consists essentially of: (1) a soluble, gelable peptide salt, and (2) up to 30 percent by weight of a pharmaceutically acceptable, monomeric, solu ...


5
Cherif Cheikh Roland: Sustained release of peptides from pharmaceutical compositions. Delab, tang weijie, October 18, 2006: CN200610009390

The invention features a solid, non-particulate, sustained-release pharmaceutical composition for parenteral administration to a patient. The composition consists essentially of: (1) a soluble, gelable peptide salt, and (2) up to 30 percent by weight of a pharmaceutically acceptable, monomeric, solu ...


6
R Cherif Cheikh: Sustained release of peptides from pharmaceutical compositions. Societe de Conseils de Recherches Et D Applications Scientifiques, TANG WEIJIE, November 19, 1997: CN95195473

The invention features a solid, non-particulate, sustained-release pharmaceutical composition for parenteral administration to a patient. The composition consists essentially of: (1) a soluble, gelable peptide salt, and (2) up to 30 percent by weight of a pharmaceutically acceptable, monomeric, solu ...


7
Cheikh Roland Cherif: Sustained release of peptides from pharmaceutical compositions. Sod Conseils Rech Applic, Jiao Liya, December 2, 2009: CN200910149197

The invention relates to a solid, non-particulate, sustained-release pharmaceutical composition for parenteral administration to a patient. The composition consists essentially of: (1) a soluble, gelable peptide salt, and (2) up to 30 percent by weight of a pharmaceutically acceptable, monomeric, so ...


8
Cherif Cheikh Roland: Sustained release of peptides from pharmaceutical compositions. Societe de Conseils de Recherches Et D Applications Scientifiques, Cherif Cheikh Roland, VOSSIUS Volker, March 14, 1996: WO/1996/007398

The invention features a solid, non-particulate, sustained-release pharmaceutical composition for parenteral administration to a patient. The composition consists essentially of: (1) a soluble, gelable peptide salt, and (2) up to 30 percent by weight of a pharmaceutically acceptable, monomeric, solu ...


9
Cherif Cheikh Roland: Sustained release of peptides from pharmaceutical compositions. Sod Conseils Rech Applic, June 25, 1997: EP0779805-A2

The invention features a solid, non-particulate, sustained-release pharmaceutical composition for parenteral administration to a patient. The composition consists essentially of: (1) a soluble, gelable peptide salt, and (2) up to 30 percent by weight of a pharmaceutically acceptable, monomeric, solu ...


10
Roland Cherif Cheikh: Sustained release of peptides from pharmaceutical compositions. Delab, December 31, 2003: KR1020017002056

The invention features a solid, non-particulate, sustained-release pharmaceutical composition for parenteral administration to a patient. The composition consists essentially of: (1) a soluble, gelable peptide salt, and (2) up to 30 percent by weight of a pharmaceutically acceptable, monomeric, solu ...